Evoke Wealth’s 1Life Healthcare ONEM Stock Holding History

Evoke Wealth’s Portfolio ONEM Stock Details ONEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-239	Closed	-$3K	–	1277
2022 Q1	$3K	Buy	+239	New	+$2.68K	﹤0.01%	1020

Other funds holding ONEM

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ATGP

Addition Three General Partner New York $45.4M AUM 15.31% 1-Year Est. Return

SHG

Sheares Healthcare Group Singapore $1.69M AUM 4.89% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

OMC

Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Evoke Wealth's ONEM Position: Q2 2022 in Review

Evoke Wealth sold out of 1Life Healthcare (ONEM) in Q2 2022, closing a stake of 239 shares — an estimated $3K sold.

Evoke Wealth first reported a position in ONEM in Q1 2022 and held it in 1 quarter. The position peaked at $3K in Q1 2022. 187 funds tracked by Wall St. Rank hold ONEM as of Q2 2022.

Evoke Wealth reported no remaining 1Life Healthcare position as of Q2 2022 after selling out during the quarter.
Evoke Wealth sold 239 1Life Healthcare shares in Q2 2022, an estimated $3K.
Evoke Wealth first reported a position in 1Life Healthcare in Q1 2022 and held it in 1 quarter.
Evoke Wealth's 1Life Healthcare position peaked at $3K in Q1 2022.
187 funds tracked by Wall St. Rank held 1Life Healthcare as of Q2 2022.

Based on Evoke Wealth's 13F filing for Q2 2022, filed 4 Aug 2022.